Vimarsana
Biggest News Aggregation in the World

Page 35 - First Author News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from First Author. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In First Author Today - Breaking & Trending Today

Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer - Vimarsana News

Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer

Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung cancer Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in The Journal of Molecular Diagnosis, published by Elsevier, investigators provide for the first time a complete overview of biomarker testing, spanning multiple treatment lines, in a single cohort of patients. Using exploratory data analysis and process-mining techn...

Research reveals increased risk of COVID-19 among women with PCOS - Vimarsana News

Research reveals increased risk of COVID-19 among women with PCOS

Women with polycystic ovary syndrome (PCOS) are at a significantly increased risk of contracting COVID-19 than women without the condition, new research led by the University of Birmingham has revealed.

Unstable initiation by young people to working life is linked with poorer mental health - Vimarsana News

Unstable initiation by young people to working life is linked with poorer mental health

A new study reveals that a precarious, unstable initiation by young people to working life is associated with poorer future mental health.

The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2 - Vimarsana News

The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2

 E-Mail IMAGE: Joaquín Arribas, co-Program Director of Preclinical and Translational Research at VHIO, ICREA Professor, CIBERONC Investigator, Director of the Hospital del Mar Medical Research Institute (IMIM). view more  Credit: VHIO Redirection of lymphocytes, via T-cell bispecific antibodies (TCBs) and chimeric antigen receptors (CARs), is already approved to treat some hematologic malignancies. In solid tumors these immune-based strategies continue to fail. Research led by Joaquín Arribas, co-Program Director of Preclinical and Translational Research at VHIO, has now show...

Study provides insight into the genetic landscape of polycystic kidney disease in Ireland - Vimarsana News

Study provides insight into the genetic landscape of polycystic kidney disease in Ireland

Study provides insight into the genetic landscape of polycystic kidney disease in Ireland A study has described genetic changes in patients with the most common form of hereditary kidney disease that affects an estimated 12.5 million people worldwide. The research, which focussed on Polycystic Kidney Disease (PKD) in Ireland, provides insights into PKD that will assist doctors and patients in the management of this of inherited condition. The study, led by researchers from the RCSI University of Medicine and Health Sciences, is published in the European Journal of Human Genetics. Related Sto...